A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Clinical trial NCT06501196 · RECRUITING

Trial details

NCT number: NCT06501196
Sponsor: BlossomHill Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Preleukemia Myelodysplastic Syndromes Refractory Acute Myeloid Leukemia

Start date: 2024-06-19
Primary completion: 2026-06-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.